Venous Hypertension (Chronic Venous Insufficiency) Support Protocol
Primary Stack
Core supplements with strongest evidenceContains aescin; strengthens venous walls; reduces permeability and edema; well-studied for CVI
Flavonoids that strengthen capillaries; reduce inflammation; improve lymphatic drainage
Supporting Stack
Additional supplements for enhanced resultsContains proanthocyanidins; reduces capillary permeability; antioxidant
Supporting Studies (1)
Antioxidant; strengthens capillaries; reduces edema; studied for CVI
Supporting Studies (1)
Contains triterpenes; strengthens connective tissue; improves microcirculation
Supporting Studies (1)
Contains ruscogenins; venotonic effects; reduces leg heaviness and swelling
Essential for collagen synthesis; supports vein wall integrity
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Venous hypertension occurs when the pressure in the leg veins becomes abnormally high, usually due to faulty valves that allow blood to flow backward (chronic venous insufficiency). This leads to blood pooling in the legs and a cascade of problems.
HOW IT DEVELOPS:
SYMPTOMS:
PROGRESSION (CEAP Classification):
MANAGEMENT:
* Horse chestnut extract is as effective as compression stockings in some studies.
* Diosmin/hesperidin is widely used in Europe with strong evidence.
* Grape seed and pine bark extracts provide additional vascular support.
Expected timeline: Supplements may improve symptoms within 4-8 weeks. Compression and lifestyle measures provide ongoing benefit.
Clinical Perspective
Venous Hypertension/Chronic Venous Insufficiency (CVI): Sustained elevated venous pressure from valve incompetence and/or obstruction. Pathophysiology: reflux causes ambulatory venous hypertension, capillary leakage, inflammation, tissue changes. Classification: CEAP (Clinical-Etiology-Anatomy-Pathophysiology). Complications: dermatitis, lipodermatosclerosis, venous ulcers (6% of CVI patients).
CRITICAL: Compression therapy is cornerstone - 20-30 mmHg for mild, 30-40 mmHg for moderate-severe/ulcers. Leg elevation, exercise (walking, calf raises), weight management. Venoactive drugs (horse chestnut, MPFF) have good evidence for symptom relief. Procedures (ablation, sclerotherapy) for symptomatic varicose veins. Ulcer management: compression plus wound care.
* Horse Chestnut (A-grade): Aescin; venotonic. Cochrane: (PMID: 22419450). 300mg (50mg aescin) BID. Comparable to compression in some trials.
* Diosmin/Hesperidin (A-grade): MPFF. Meta-analysis: (PMID: 25277016). 500/50mg BID. Standard therapy in Europe.
* Grape Seed Extract (B-grade): Proanthocyanidins. Review: (PMID: 26882542). 150-300mg daily.
* Pycnogenol (B-grade): Pine bark. Systematic review: (PMID: 23859064). 100-200mg daily.
* Gotu Kola (B-grade): Triterpenes. Review: (PMID: 23099266). 60-120mg triterpenes daily.
* Butcher's Broom (B-grade): Ruscogenins. Cochrane: (PMID: 16764907). 150mg BID.
* Vitamin C (C-grade): Collagen synthesis. Review: (PMID: 23075608). 500-1000mg daily.
Assessment targets: Leg circumference, symptom scores, skin changes, ulcer healing (if present), quality of life.
Protocol notes: Compression: essential; graduated stockings; compliance is key; apply in morning before standing. Exercise: walking activates calf muscle pump; avoid prolonged standing/sitting. Weight: obesity increases venous pressure; weight loss beneficial. Elevation: legs above heart when resting; reduces edema. Skin care: emollients; avoid trauma; treat dermatitis. Ulcers: compression bandaging essential; wound care; consider pentoxifylline adjunct. DVT history: may cause post-thrombotic syndrome; anticoagulation affects management. Procedures: endovenous ablation, sclerotherapy for symptomatic varicose veins; ultrasound evaluation first. Supplements: can combine multiple venoactive agents; work synergistically with compression. Flying/travel: compression stockings for long flights; stay hydrated; move periodically.